Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Mitchell

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Research Involvement and Engagement|October 25, 2017
Priority setting in research: user led mental health researchMarjorie Ghisoni, Christine Ann Wilson, Karen Morgan, et al.
Lung Cancer (Amsterdam, Netherlands)|March 25, 2018
Phase II trial of preoperative pemetrexed plus carboplatin in patients with stage IB-III nonsquamous non-small cell lung cancer (NSCLC)John D Hainsworth, David M Waterhouse, Kent C Shih, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 18, 2011
Randomized, double-blind, placebo-controlled, phase II trial of sorafenib and erlotinib or erlotinib alone in previously treated advanced non-small-cell lung cancerDavid R Spigel, Howard A Burris, F Anthony Greco, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 20, 2008
American Society of Clinical Oncology 2008 clinical practice guideline update: use of chemotherapy and radiation therapy protectantsMartee L Hensley, Karen L Hagerty, Tarun Kewalramani, et al.
Physical Review Letters|December 27, 2015
Oxidation-Induced Surface Roughening of Aluminum Nanoparticles Formed in an Ablation PlumeGeorg Daniel Förster, Marie Girault, Jérôme Menneveux, et al.
Journal for Immunotherapy of Cancer|October 28, 2021
Real-world performance of blood-based proteomic profiling in first-line immunotherapy treatment in advanced stage non-small cell lung cancerPatricia Rich, R Brian Mitchell, Eric Schaefer, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Research Involvement and Engagement|October 25, 2017
Priority setting in research: user led mental health researchMarjorie Ghisoni, Christine Ann Wilson, Karen Morgan, et al.
Lung Cancer (Amsterdam, Netherlands)|March 25, 2018
Phase II trial of preoperative pemetrexed plus carboplatin in patients with stage IB-III nonsquamous non-small cell lung cancer (NSCLC)John D Hainsworth, David M Waterhouse, Kent C Shih, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 18, 2011
Randomized, double-blind, placebo-controlled, phase II trial of sorafenib and erlotinib or erlotinib alone in previously treated advanced non-small-cell lung cancerDavid R Spigel, Howard A Burris, F Anthony Greco, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 20, 2008
American Society of Clinical Oncology 2008 clinical practice guideline update: use of chemotherapy and radiation therapy protectantsMartee L Hensley, Karen L Hagerty, Tarun Kewalramani, et al.
Physical Review Letters|December 27, 2015
Oxidation-Induced Surface Roughening of Aluminum Nanoparticles Formed in an Ablation PlumeGeorg Daniel Förster, Marie Girault, Jérôme Menneveux, et al.
Journal for Immunotherapy of Cancer|October 28, 2021
Real-world performance of blood-based proteomic profiling in first-line immunotherapy treatment in advanced stage non-small cell lung cancerPatricia Rich, R Brian Mitchell, Eric Schaefer, et al.
Pageof 4